| Features: chemotherapy drug |
| Etoposide (VP-16) — Conventional cytotoxic chemotherapy drug and semisynthetic podophyllotoxin derivative that inhibits DNA topoisomerase II. Etoposide stabilizes the transient DNA-topoisomerase II cleavage complex, preventing religation of cleaved DNA strands and causing accumulation of DNA strand breaks, inhibition of DNA replication and transcription, cell-cycle arrest, and apoptotic cell death. Drug class: Conventional chemotherapy / Topoisomerase II inhibitor / Podophyllotoxin derivative. Primary mechanism: Topoisomerase II inhibition → DNA strand breaks ↑ → DNA replication and transcription ↓ → DNA damage response ↑ → G2/S-phase cell-cycle arrest ↑ → apoptosis ↑. Typical target/pathway effects: TOP2A/TOP2B inhibition; DNA double-strand breaks ↑; DNA damage ↑; γH2AX ↑; G2 arrest ↑; replication ↓; proliferation ↓; caspase activation ↑; apoptosis ↑. Cancer relevance: Strong. Etoposide is an established cytotoxic anticancer drug used in multiple chemotherapy regimens, particularly for small-cell lung cancer, testicular germ-cell tumors, lymphomas, leukemias, and selected pediatric and solid tumors. |
| 8749- | MeSA, | etoposide, | Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo |
| - | in-vivo, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:495 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid